The control of T cell responses by dendritic cell subsets

Current Opinion in Immunology

Volumn 12, Issue 1, 2000, Pages 114-121

  Reid, Steven D ^a   Penna, Giuseppe ^a   Adorini, Luciano ^a  

^a ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; CELL POLARITY; CELL SUBPOPULATION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CYTOKINES; DENDRITIC CELLS; HUMANS; MICE; T-LYMPHOCYTES;

EID: 0033966740     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00059-X     Document Type: Review

References (77)

1. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 9:1991;271-296.
2. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252. An authoritative and thorough review of the several facets of DCs.
3. Bell D., Young J.W., Banchereau J. Dendritic cells. Adv Immunol. 72:1999;255-324. A good, recent review on DCs.
4. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 182:1995;389-400.
5. Cella M., Sallusto F., Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 9:1997;10-16.
6. 5 integrin and cross-presentation on MHC class I molecules.
7. Cyster J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med. 189:1999;447-450.
8. + T cell help.
9. Macatonia S.E., Hosken N.A., Litton M., Vieira P., Hsieh C.S., Culpepper J.A., Wysocka M., Trinchieri G., Murphy K.M., O'Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 154:1995;5071-5079.
10. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 184:1996;747-752.
11. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., Romani N., Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med. 184:1996;741-746.
12. Hilkens C.M., Kalinski P., de Boer M., Kapsenberg M.L. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood. 90:1997;1920-1926.
13. Ria F., Penna G., Adorini L. Th1 cells induce and Th2 inhibit antigen dependent IL-12 secretion by dendritic cells. Eur J Immunol. 28:1998;2003-2016. Antigen-specific Th1 cells induce the production of IL-12 from DCs, whereas IL-10 produced by Th2 cells can prevent IL-12 secretion.
14. + T cells. Microglia functionally resemble DCs, except for an inferior capacity to prime naïve T cells.
15. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 90:1997;3245-3287.
16. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 176:1992;1693-1702.
17. Vremec D., Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol. 159:1997;565-573.
18. Leenen P.J., Radosevic K., Voerman J.S., Salomon B., van Rooijen N., Klatzmann D., van Ewijk W. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol. 160:1998;2166-2173. This paper (with [17]) describes DC subsets from mouse secondary lymphoid organs, with a fairly comprehensive description of their phenotype.
19. Pulendran B., Lingappa J., Kennedy M.K., Smith J., Teepe M., Rudensky A., Maliszewski C.R., Maraskovsky E. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol. 159:1997;2222-2231.
20. Wu L., Vremec D., Ardavin C., Winkel K., Suss G., Georgiou H., Maraskovsky E., Cook W., Shortman K. Mouse thymus dendritic cells: kinetics of development and changes in surface markers during maturation. Eur J Immunol. 25:1995;418-425.
21. Saunders D., Lucas K., Ismaili J., Wu L., Maraskovsky E., Dunn A., Shortman K. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J Exp Med. 184:1996;2185-2196.
22. + DCs.
23. - DCs inducing Th2 responses in vivo. Experiments were also performed using Flt-3L and GM-CSF-treated mice, which preferentially expand the lymphoid and myeloid populations, respectively. Additionally, the humoral response was measured, demonstrating that LDCs and MDCs are able to generate Th1- and Th2-type antibody responses.
24. + DCs did not travel to the draining lymph node following injection into the hind footpad, but were still able to prime T cells.
25. Kurts C., Kosaka H., Carbone F.R., Miller J.F., Heath W.R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med. 186:1997;239-245.
26. Suss G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med. 183:1996;1789-1796.
27. Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol Today. 19:1998;448-454.
28. Inaba K., Turley S., Yamaide F., Iyoda T., Mahnke K., Inaba M., Pack M., Subklewe M., Sauter B., Sheff D.et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med. 188:1998;2163-2173. The authors demonstrate that mouse, immature dendritic cells phagocytose both necrotic and apoptotic human and mouse B cell blasts, and present MHC derived peptides.
29. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med. 184:1996;923-930.
30. Sato M., Iwakabe K., Kimura S., Nishimura T. Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines. Immunol Lett. 67:1999;63-68.
31. Sousa C.R., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med. 186:1997;1819-1829.
32. Ohteki T., Fukao T., Suzue K., Maki C., Ito M., Nakamura M., Koyasu S. Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med. 189:1999;1981-1986. LDCs from RAG-2-deficient, natural-killer-cell-depleted mice produce IFN-γ.
33. + blasts.
34. Kellermann S.A., Hudak S., Oldham E.R., Liu Y.J., McEvoy L.M. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol. 162:1999;3859-3864.
35. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med. 184:1996;695-706.
36. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med. 180:1994;83-93.
37. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA. 93:1996;2588-2592.
38. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 189:1999;821-829. This work describes the maturation of DCs by influenza virus and double-stranded RNA, their production of type I interferons and the expression of MxA, which protects against the cytopathic effects of viral infection.
39. Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J., Brand A., Goulmy E. Polyriboinosinic polyribocytidylic acid (poly[I:C]) induces stable maturation of functionally active human dendritic cells. J Immunol. 163:1999;57-61. Poly(I:C) can lead to the maturation of DCs, increasing their co-stimulatory molecule expression, production of IL-12 and the capacity to induce strong alloresponses.
40. Rescigno M., Granucci F., Citterio S., Foti M., Ricciardi-Castagnoli P. Coordinated events during bacteria-induced DC maturation. Immunol Today. 20:1999;200-203.
41. Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L., Zimmermann V.S., Davoust J., Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med. 185:1997;317-328.
42. Kalinski P., Schuitemaker J.H., Hilkens C.M., Kapsenberg M.L. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J Immunol. 161:1998;2804-2809.
43. Randolph G.J., Beaulieu S., Lebecque S., Steinman R.M., Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science. 282:1998;480-483. DCs can be generated quickly, in two days, from monocytes that have migrated through an endothelial layer in vitro and back again. In the presence of zymosan, this process is more efficient.
44. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 185:1997;1101-1111.
45. + T helper cell responses. MDCs (DC1) and plasmacytoid-derived DCs (DC2) were co-cultured with T cells and the ensuing cytokine secretion measured. DC1 cells induced T cells of a Th1 phenotype, and DC2, a Th2 phenotype. Unlike DC2, DC1 secreted high levels of IL-12, but IL-4 production by DC2 could not be detected at the protein or mRNA level. A regulatory mechanism for the differentiation of Th cells based on DC subsets is proposed.
46. Olweus J., Bitmansour A., Warnke R., Thompson P.A., Carballido J., Picker L.J., Lund-Johansen F. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA. 94:1997;12551-12556.
47. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 5:1999;919-923. This is the first observation that the progenitor of plasmacytoid DCs are able to produce type I interferons which aid T cell survival.
48. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1999;1835-1837.
49. de Saint-Vis B., Fugier-Vivier I., Massacrier C., Gaillard C., Vanbervliet B., Ait-Yahia S., Banchereau J., Liu Y.J., Lebecque S., Caux C. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol. 160:1998;1666-1676.
50. •]) are key papers describing the differential production of chemokines and their expression during DC maturation.
51. •].
52. •].
53. Sallusto F., Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med. 189:1999;611-614.
54. •].
55. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med. 189:1999;451-460. Mice deficient in the chemokine SLC (plt mice) are examined for DC migration to secondary lymphoid organs. Lack of SLC prevents DC and naïve T cell migration to draining lymph nodes.
56. Matsue H., Edelbaum D., Hartmann A.C., Morita A., Bergstresser P.R., Yagita H., Okumura K., Takashima A. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J Immunol. 162:1999;5287-5298.
57. Wang J., Zheng L., Lobito A., Chan F.K., Dale J., Sneller M., Yao X., Puck J.M., Straus S.E., Lenardo M.J. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 98:1999;47-58. Patients with a caspase-10 mutation exhibit abnormal lymphocyte and DC apoptosis with normal Fas/FasL expression. This lack of DC apoptosis could be partly responsible for the generation and maintenance of autoimmunity.
58. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med. 188:1998;1493-1501.
59. Dhodapkar M.V., Steinman R.M., Sapp M., Desai H., Fossella C., Krasovsky J., Donahoe S.M., Dunbar P.R., Cerundolo V., Nixon D.F., Bhardwaj N. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest. 104:1999;173-180. Human DCs used as adjuvants for recall and viral antigens can effectively stimulate both helper and cytotoxic T cell responses.
60. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med. 4:1998;328-332. Using DCs generated from patients pulsed with tumour lysates or tumour-related peptides, a beneficial response was induced in some individuals.
61. Nishioka Y., Hirao M., Robbins P.D., Lotze M.T., Tahara H. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res. 59:1999;4035-4041.
62. Kaplan J.M., Yu Q., Piraino S.T., Pennington S.E., Shankara S., Woodworth L.A., Roberts B.L. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. J Immunol. 163:1999;699-707.
63. Chiodoni C., Paglia P., Stoppacciaro A., Rodolfo M., Parenza M., Colombo M.P. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J Exp Med. 190:1999;125-133. Tumour cells transfected with GM-CSF and CD154 were able to stimulate anti-tumour responses by augmenting the APC function of tumour-infiltrating DCs.
64. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 4:1998;594-600.
65. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 159:1997;4772-4780.
66. Morel A.S., Quaratino S., Douek D.C., Londei M. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol. 27:1997;26-34.
67. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., Di Carlo V. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol. 162:1999;6473-6481.
68. Groux H., Cottrez F., Rouleau M., Mauze S., Antonenko S., Hurst S., McNeil T., Bigler M., Roncarolo M.G., Coffman R.L. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol. 162:1999;1723-1729.
69. Krasteva M., Kehren J., Horand F., Akiba H., Choquet G., Ducluzeau M.T., Tedone R., Garrigue J.L., Kaiserlian D., Nicolas J.F. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol. 160:1998;1181-1190.
70. Fu F., Li Y., Qian S., Lu L., Chambers F., Starzl T.E., Fung J.J., Thomson A.W. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 62:1996;659-665.
71. Thomson A.W., Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation. 68:1999;1-8.
72. Shlomchik W.D., Couzens M.S., Tang C.B., McNiff J., Robert M.E., Liu J., Shlomchik M.J., Emerson S.G. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 285:1999;412-415.
73. Ito T., Inaba M., Inaba K., Toki J., Sogo S., Iguchi T., Adachi Y., Yamaguchi K., Amakawa R., Valladeau J.et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol. 163:1999;1409-1419. This is a detailed analysis of the precursors of human DCs obtained from blood.
74. Kohrgruber N., Halanek N., Groger M., Winter D., Rappersberger K., Schmitt-Egenolf M., Stingl G., Maurer D. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol. 163:1999;3250-3259. Two different DC populations were identified on the basis of their expression of CD11c and response to cytokines.
75. Kalinski P., Hilkens C.M.U., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today. 20:1999;561-567.
76. - dendritic cells to enhance presentation of a tumor peptide in vivo. J Immunol. 163:1999;3100-3105.
77. Rodewald H.R., Brocker T., Haller C. Developmental dissociation of thymic dendritic cell and thymocyte lineages revealed in growth factor receptor mutant mice. Proc Natl Acad Sci USA. 76:1999;15065-15073.